Skip to content
Disclosery

EXANE DERIVATIVES: PYPL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PYPL, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 21,626 PYPL shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 21,626 shares
    Change vs previous 13F -919 shares

    0.87% of the 13F portfolio, value $1,510,201.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 22,545 shares
    Change vs previous 13F +4,564 shares

    0.73% of the 13F portfolio, value $2,607,347.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 17,981 shares
    Change vs previous 13F -921 shares

    0.82% of the 13F portfolio, value $3,390,966.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 18,902 shares
    Change vs previous 13F +297 shares

    1.23% of the 13F portfolio, value $4,918,650.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 18,605 shares
    Change vs previous 13F -995 shares

    1.31% of the 13F portfolio, value $5,603,742.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 19,600 shares
    Change vs previous 13F -8,577 shares

    1.43% of the 13F portfolio, value $4,759,845.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 28,177 shares
    Change vs previous 13F -685 shares

    2% of the 13F portfolio, value $6,599,290.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 28,862 shares
    Change vs previous 13F not available

    1.85% of the 13F portfolio, value $5,686,755.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).